Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v2-FR Version v2-FR
Language French French
Date Updated 2020-01-28 2020-01-28
Drug Identification Number 00816086 00816086
Brand name FOLIC ACID INJECTION USP FOLIC ACID INJECTION USP
Common or Proper name FOLIC ACID FOLIC ACID
Company Name SANDOZ CANADA INCORPORATED SANDOZ CANADA INCORPORATED
Ingredients FOLIC ACID FOLIC ACID
Strength(s) 5MG 5MG
Dosage form(s) LIQUID LIQUID
Route of administration INTRAMUSCULAR INTRAVENOUS SUBCUTANEOUS INTRAMUSCULAR INTRAVENOUS SUBCUTANEOUS
Packaging size 10ml X 1 vial 10ml X 1 vial
ATC code B03BB B03BB
ATC description VITAMIN B12 AND FOLIC ACID VITAMIN B12 AND FOLIC ACID
Reason for discontinuation Business reasons Business reasons
Anticipated discontinuation date
Actual discontinuation date 2019-04-30 2019-04-30
Remaining supply date 2019-12-02 2019-12-02
Discontinuation status Discontinued Discontinued
Discontinuation decision reversal no no
Tier 3 Status No No
Information on remaining supply
Company comments
Health Canada comments